Transgene Biotek Profit & Loss Annual

Trade
BSE: 526139 | NSE: - | ISIN: INE773D01018 | Sector: Biotechnology & Drugs
6.52 +0.03 (0.46%)Updated : 26 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 0.230.060.090.17
Total Revenue 0.230.060.090.17
Costof Revenue Total 0.000.07-0.050.06
Gross Profit 0.23-0.010.130.11
Selling/ General/ Admin Expenses Total 0.310.300.290.25
Depreciation/ Amortization 0.094.959.929.91
Other Operating Expenses Total 0.540.740.310.39
Total Operating Expense 0.946.0610.4710.60
Operating Income -0.71-6.00-10.39-10.44
Interest Inc( Exp) Net- Non- Op Total -1.29-1.81-2.27-2.66
Other Net 0.180.180.210.27
Net Income Before Taxes -0.66-6.01-10.40-10.43
Provisionfor Income Taxes 0.000.000.00-
Net Income After Taxes -0.66-6.01-10.40-10.43
Net Income Before Extra Items -0.66-6.01-10.40-10.43
Net Income -0.66-6.01-10.40-10.43
Income Availableto Com Excl Extra Ord -0.66-6.01-10.40-10.43
Income Availableto Com Incl Extra Ord -0.66-6.01-10.40-10.43
Diluted Net Income -0.66-6.01-10.40-10.43
Diluted Weighted Average Shares 7.287.587.587.58
Diluted EPS Excluding Extra Ord Items -0.09-0.79-1.37-1.38
Diluted Normalized EPS -0.09-0.79-1.37-1.38
Gain( Loss)on Saleof Assets -0.000.000.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,504.70+44.10(1.79%)
1,921.85+32.70(1.73%)
589.05+6.30(1.08%)
11,105.00-351.85 (-3.07%)
HomeMarketsPremiumInstant LoanMint Shorts